| Status | Study |
| Not yet recruiting |
Study Name: Individualized Cognitive Training in HIV Condition: HIV-Associated Cognitive Motor Complex Aging Date: 2017-04-11 Interventions: Behavioral: Individualized Cognitive Training |
| Recruiting |
Study Name: Intranasal Insulin for the Treatment of HAND Condition: HIV Dementia HIV-Associated Cognitive Mot Date: 2017-03-09 Interventions: Drug: Insulin, intranasal Regu |
| Recruiting |
Study Name: SOLFAMU Study of Nasal Brushing Collected OLFActory MUcosa Samples in the Diagnosis of Human Encephalopathies Condition: Encephalopathy HIV-encephalopathy Alzheimer Dementia Date: 2016-10-27 Interventions: Device: Nasal Brushing Nasal brushing will be performed in non-sedated patients as follows. After admini |
| Recruiting |
Study Name: Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS Condition: AIDS Dementia Complex Date: 2016-02-02 Interventions: Drug: Ferumoxytol All subjects will receive neurocognitive testing. Subjects will have a brain MRI prior |
| Terminated |
Study Name: Effect of Cobicistat Versus Ritonavir Boosting on the Brain Permeation of Darunavir in HIV-infected Individuals Condition: AIDS-related Dementia Complex Date: 2015-07-09 Interventions: Drug: Darunavir darunavir 800 |
| Recruiting |
Study Name: Evaluation of the Role of OCT in the Detection of HIV-associated Neurocognitive Disorder Condition: AIDS-Related Dementia Complex Date: 2015-04-22 Interventions: Other: Optical Coherence Tomography Optical Coherence Tomography provides a non invasive evaluation of t |
| Recruiting |
Study Name: A Prospective Observational Trial to Determine Cardiovascular Diseases in HIV-infected Patients Condition: HIV-infection Coronary Heart Disease Myocardial Infarction Date: 2014-10-21 Interventions: Other: Comprehensive non invasive cardiovascular examination |
| Recruiting |
Study Name: Maraviroc and NeuroAIDS Pathogenesis Condition: AIDS Dementia Complex Date: 2014-06-05 Interventions: Drug: Maraviroc Maraviroc admi |
| Completed |
Study Name: Effect of Cenicriviroc on HIV Neurocognitive Impairment Condition: AIDS Dementia Complex HIV-1-Associated Cognitive Motor Complex Date: 2013-09-04 Interventions: Drug: cenicriviroc cenicriviroc given once daily for 24 weeks; number of pills dependent on recommended |
| Completed |
Study Name: Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders Condition: HIV Dementia Date: 2012-08-13 Interventions: Drug: Ferumoxytol A dose of 4 mg/kg of ferumoxytol up to a maximum of 510 mg of elemental iron will be a |